Beta Cell Differentiation and Cell Assay
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N92022Q0468
- Agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks services related to beta cell differentiation and cell assays. The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute requires the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. Proposals will be evaluated based on the offeror's technical approach, qualifications, and price. The due date for proposals is September 20, 2022.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code R425. The potential period of performance is one year. Services are to be performed in Bethesda, Maryland. Award amounts have not been specified but are expected to be under $500,000 based on previous similar contracts. The required cell assays must be developed and validated within six months of award.
Notice text
Beta Cell Differentiation and Cell Assay
Notice history
| Notice | Type | Posted |
|---|---|---|
| Beta Cell Differentiation and Cell Assay | Award Notice | |
| Beta Cell Differentiation and Cell Assay | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity